A gene expression signature predicts recurrence-free survival in meningioma
Adriana Olar(Medical University of South Carolina), Erik P. Sulman(The University of Texas MD Anderson Cancer Center)
Cited by 31
Related Papers
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
|Acta Neuropathologica|2015|350
Phosphohistone H3: implications for clinical practice and risk assessment in meningioma
|Neuro-Oncology|2015|9